These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 672732)

  • 1. Labetalol in hypertensive emergencies.
    MacCarthy EP; Frost GW; Stokes GS
    Med J Aust; 1978 Apr; 1(7):399-400. PubMed ID: 672732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypertensive emergencies: clinical evaluation of the use of a new drug: labetalol hydrochloride].
    Rossano P; Saffiotti O; Mayer MC; Blasich M; Rossano G; Bellotti P
    Minerva Cardioangiol; 1980 May; 28(5):309-14. PubMed ID: 6111048
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous labetalol in the management of severe hypertension and hypertensive emergencies.
    Cressman MD; Vidt DG; Gifford RW; Moore WS; Wilson DJ
    Am Heart J; 1984 May; 107(5 Pt 1):980-5. PubMed ID: 6720529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of hypertensive crises with a mono-substance with alpha- and beta-blocking properties (labetalol)].
    Holzer H; Pogglitsch H; Katschnig H; Korthals C
    Wien Med Wochenschr Suppl; 1981; 69():10-3. PubMed ID: 6952657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of labetalol in the treatment of severe drug-resistant hypertension.
    Morgan T; Gillies A; Morgan G; Adam W
    Med J Aust; 1978 Apr; 1(7):393-6. PubMed ID: 672730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labetalol in hypertensive emergencies.
    Wing LM
    Med J Aust; 1978 Jun; 1(12):658. PubMed ID: 683092
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of labetalol with other anti-hypertensive drugs.
    Prichard BN; Richards DA
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):41S-47S. PubMed ID: 6124265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labetalol in resistant hypertension.
    Hedstrand H
    Acta Med Scand Suppl; 1982; 665():125-8. PubMed ID: 6961758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labetalol: an alpha- and beta-adrenoceptor blocking drug.
    Michelson EL; Frishman WH
    Ann Intern Med; 1983 Oct; 99(4):553-5. PubMed ID: 6137987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of the alpha- and beta-adrenergic blocker labetalol in hypertensive crises].
    Kharchenko VI; Savenkov PM; Romanova LV; Arkhipov SN; Borisova GG
    Sov Med; 1983; (9):84-8. PubMed ID: 6648691
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous labetalol in the emergency treatment of hypertension.
    Vidt DG
    J Clin Hypertens; 1985 Jun; 1(2):179-86. PubMed ID: 3915322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hypertensive emergencies with oral labetalol.
    Good CS
    Br Med J; 1978 Aug; 2(6135):501-2. PubMed ID: 678942
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergency treatment of severe hypertension with intravenous labetalol.
    McGrath BP; Matthews PG; Walter NM; Maydom BW; Johnston CI
    Med J Aust; 1978 Oct; 2(9):410-1. PubMed ID: 732728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labetalol in hypertensive emergencies.
    Br Med J; 1978 Sep; 2(6139):772. PubMed ID: 698718
    [No Abstract]   [Full Text] [Related]  

  • 16. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects.
    MacCarthy EP; Bloomfield SS
    Pharmacotherapy; 1983; 3(4):193-219. PubMed ID: 6310529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labetalol infusion in hypertensive emergencies.
    Lebel M; Langlois S; Belleau LJ; Grose JH
    Clin Pharmacol Ther; 1985 Jun; 37(6):615-8. PubMed ID: 3891186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
    Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Trust PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
    J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hypertension by labetalol (author's transl)].
    Sternon J; Melot C; Contu E
    Rev Med Brux; 1980 Nov; 1(9):615-21. PubMed ID: 7455430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.